Many of the global guidelines for kidney cancer are listed here. Patient organisations often use these guidelines to help patients advocate for best quality standards of care.

If your country does not have guidelines for kidney cancer, the most commonly used guidelines are those published by the EAU. The IKCC and its affiliate organisations plays an important role on multiple guidelines committees to ensure that the patient voice is well represented.

Country/Region of OriginSponsoring
Title or Type
of Guideline
CanadaCanadian Urological Association (CUA)English

> 2015 - Canadian guideline for the management of small renal masses
> 2014 - Surgical management of renal cell carcinoma Canadian Kidney Cancer Forum Consensus
> 2017 - Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update
> 2017 - CUA guideline on the management of cystic renal lesions
> 2016 - Structured assessment and followup for patients with hereditary kidney tumour syndromes
> 2018 - Canadian guideline on genetic screening for hereditary renal cell cancers
> 2018 - Canadian Urological Association guideline for followup of patients after treatment of non-metastatic renal cell carcinoma
EuropeEuropean Association of Urology (EAU)English
Pусский язык
> 2022 - EAU Guidelines on Renal Cell Carcinoma
> 2018 - EAU Guidelines on Renal Cell Carcinoma - Russian (Клинические рекомендации по почечно-клеточному раку), Russian Society of Oncourology
> 2011 - Renal Cell Carcinoma pocket - Serbian, Serbian Association of Urology
> 2010 - Urologické Listy condensed EAU Guidelines on Renal Cell Carcinoma - Czech (Pro léčbu karcinomu z renálních buněk)
> 2009 - Renal Cell Carcinoma pocket - Portuguese, Portuguese Association of Urology

EuropeEuropean Society for Medical Oncology (ESMO)English> 2020 - eUpdate – Renal Cell Carcinoma Treatment Recommendations
> 2019 - Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
GermanyDeutsche Gesellschaft für Urologie
(DGU), Deutsche Gesellschaft für Hämatologie und
Onkologie (DGHO) im Rahmen des Leitlinienprogramms Onkologie
Deutsch> 2017 - S3-Leitlinie Diagnostik, Therapie und Nachsorge des Nierenzellkarzinoms
MexicoMexico Oncogui RenalEspañol> 2016 - Diagnóstico y tratamiento del cáncer renal
NetherlandsNederlandse Vereniging voor UrologieDutch> 2018 - Behandelpad nierkanker
United KingdomUK National Institute for Health and Care Excellence (NICE)EnglishThe UK National Institute for Health and Care Excellence issues Guidance for treatment, especially focusing on when and how certain drugs might be used in treatment. See the index at:

> UK National Institute for Health and Care Excellence (NICE) - Kidney cancer
United KingdomUK Royal College of Radiologists (RCR)English> 2018 - Recommendations for cross-sectional imaging in cancer management, Second edition
United StatesAmerican Society of Clinical Oncology (ASCO)English> 2017 - Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline
United StatesAmerican Urological Association (AUA)English> 2017 - Renal Mass and Localized Renal Cancer
> 2013 - Ablation of Renal Masses
United StatesNational Cancer Institute (NIH)English> 2019 - Renal Cell Cancer Treatment (PDQ®)–Patient Version
United StatesNational Comprehensive Cancer Network® (NCCN®)English
Chinese 中文
> 2022 - Kidney cancer guidelines for patients English
> 2020 - Updated kidney cancer guidelines for physicians English
> 2015 - NCCN 患者指南 - 肾癌
> 2017 - Rakovina ledvin
> 2015 - NCCN - Guidelines for patients - Nierenkrebs
> 2017 - NCCN - Guidelines for patients - Cáncer de riñón
(Links provided with permission from NCCN®)
United StatesVHL AllianceEnglish
> 2020 - Active surveillance guidelines 2020


More from the InfoHUB